Emergent BioSolutions Inc

2026-09-23 20:07; UTC

Emergent BioSolutions Inc shares fell sharply as inflation concerns and higher bond yields pressured equities, despite strong recent growth in the U.S. private sector.

2026-09-22 19:51; UTC

Emergent BioSolutions Inc is advancing, currently trading around a 3% cumulative return, well above its 20-day moving average and near the upper end of its one-month range.

2026-09-21 20:02; UTC

Emergent BioSolutions Inc shares fell sharply after an early high, continuing a decline since Friday amid a broader market backdrop.

2026-09-18 19:46; UTC

Emergent BioSolutions Inc shares fell sharply, nearing their lowest point of the day after pulling back from an early morning high.

2026-09-17 20:13; UTC

Emergent BioSolutions Inc. is declining in after-market trading, following a lower close on Thursday, but remains above its 20-day moving average.

2026-09-16 20:07; UTC

Emergent BioSolutions Inc shares are significantly higher, maintaining strong performance from Tuesday, despite pulling back slightly after reaching a midday high.

2026-09-15 19:16; UTC

Emergent BioSolutions Inc shares are lower as the company cuts 90 jobs and restructures to save $40 million amid rising treasury yields and inflation concerns.

2026-09-11 20:01; UTC

Emergent BioSolutions Inc shares are higher, following a recent decline in the Michigan Consumer Sentiment Index, which fell to 47.8, below expectations.

2026-09-10 20:03; UTC

Emergent BioSolutions shares are higher today, supported by a consensus "Hold" rating and reaffirmed buy ratings from UBS and Benchmark. The average target price is $10.00.

2026-09-09 20:02; UTC

Emergent BioSolutions Inc shares are lower today, continuing a decline since Tuesday's close. No specific news was identified to explain the movement.

2026-09-08 20:08; UTC

Emergent BioSolutions Inc shares are lower following a downgrade to Hold amid concerns over declining revenues and ongoing debt issues.

2026-09-03 20:03; UTC

Emergent BioSolutions faces investigation amid $191.3 million impairment charge and $180.2 million net loss, contributing to shares trading lower today.

2026-09-02 19:53; UTC

Emergent BioSolutions Inc. is under investigation related to recent financial disclosures, following a significant net loss and reduced revenue guidance. Shares are higher today.

2026-09-01 20:09; UTC

Emergent BioSolutions secures a $24 million contract modification from BARDA for its anthrax vaccine, CYFENDUS®, as shares rise in Tuesday trading.

2026-08-31 20:02; UTC

Emergent BioSolutions secures a Canadian government contract for NARCAN® Nasal Spray, boosting shares during Monday's session. The agreement runs from October 2026 to September 2029.

2026-08-28 20:07; UTC

Emergent BioSolutions shares are lower amid an investigation by Bronstein, Gewirtz & Grossman, LLC, following a $191.3 million impairment charge and reduced revenue guidance.

2026-08-27 20:07; UTC

Emergent BioSolutions Inc. is under investigation, following a $180.2 million net loss and reduced revenue guidance, contributing to a decline in shares today.

2026-08-26 20:08; UTC

Emergent BioSolutions Inc shares are higher, reflecting strong upward momentum since Tuesday. The stock remains well above its 20-day moving average.

2026-08-25 20:07; UTC

Emergent BioSolutions Inc shares are higher during Tuesday's session, continuing a strong advance since Monday's close amid easing Treasury yields and lower oil prices.

2026-08-24 19:51; UTC

Emergent BioSolutions Inc shares are higher today, continuing a cumulative increase since Friday. The stock remains below its 20-day moving average.

2026-08-21 19:51; UTC

Emergent BioSolutions Inc shares are higher today, continuing a steady upward trend since Thursday's close. No specific news was identified to explain the movement.

2026-08-20 19:02; UTC

Emergent BioSolutions Inc faces scrutiny after a $191.3 million impairment charge and a reduced revenue outlook, contributing to a decline in shares.

2026-08-19 19:52; UTC

Emergent BioSolutions Inc is trading higher during Wednesday's session, recovering from earlier lows and reflecting strength since Tuesday's close. No specific news was identified.

2026-08-18 20:06; UTC

Emergent BioSolutions Inc shares are higher today, reflecting a broader market recovery. The stock remains below its 20-day moving average and prior month levels.

2026-08-17 19:56; UTC

Emergent BioSolutions faces investigations over financial disclosures, including a $191.3 million impairment charge, contributing to lower shares amid declining investor confidence.

2026-08-13 19:51; UTC

Emergent BioSolutions Inc shares are roughly flat as jobless claims rise to 209,000, exceeding expectations. The stock remains below its 20-day moving average.

2026-08-12 19:26; UTC

Emergent BioSolutions Inc gains amid broader market optimism following inflation data. The stock reached a session high before slightly pulling back.

2026-08-11 22:56; UTC

Emergent BioSolutions Inc shares are trading lower in after-market hours. No specific news was identified to explain the movement.

2026-08-10 19:51; UTC

Emergent BioSolutions shares are trading lower as H.C. Wainwright reduced its price target to $10.00, citing concerns over performance and outlook amid competitive pressures.

2026-08-07 23:26; UTC

Emergent BioSolutions Inc shares rose in after-market trading, amid positive market sentiment and notable gains in major tech stocks. No specific news was identified.